Englander Institute for Precision Medicine

Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.

TitlePleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.
Publication TypeJournal Article
Year of Publication2021
AuthorsClement CC, Nanaware PP, Yamazaki T, Negroni MPia, Ramesh K, Morozova K, Thangaswamy S, Graves A, Kim HJung, Li TWanxia, Vigano' M, Soni RK, Gadina M, Tse HY, Galluzzi L, Roche PA, Denzin LK, Stern LJ, Santambrogio L
JournalImmunity
Volume54
Issue4
Pagination721-736.e10
Date Published2021 Apr 13
ISSN1097-4180
KeywordsAnimals, Antigen Presentation, Antigen-Presenting Cells, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Disease Models, Animal, Epitopes, Female, Histocompatibility Antigens Class II, Male, Mice, Mice, Inbred C57BL, Peptides, Protein Binding, Stress, Physiological
Abstract

Hyperglycemia and hyperlipidemia are often observed in individuals with type II diabetes (T2D) and related mouse models. One dysmetabolic biochemical consequence is the non-enzymatic reaction between sugars, lipids, and proteins, favoring protein glycation, glycoxidation, and lipoxidation. Here, we identified oxidative alterations in key components of the major histocompatibility complex (MHC) class II molecule antigen processing and presentation machinery in vivo under conditions of hyperglycemia-induced metabolic stress. These modifications were linked to epitope-specific changes in endosomal processing efficiency, MHC class II-peptide binding, and DM editing activity. Moreover, we observed some quantitative and qualitative changes in the MHC class II immunopeptidome of Ob/Ob mice on a high-fat diet compared with controls, including changes in the presentation of an apolipoprotein B100 peptide associated previously with T2D and metabolic syndrome-related clinical complications. These findings highlight a link between glycation reactions and altered MHC class II antigen presentation that may contribute to T2D complications.

DOI10.1016/j.immuni.2021.02.019
Alternate JournalImmunity
PubMed ID33725478
PubMed Central IDPMC8046741
Grant ListP01 AG031782 / AG / NIA NIH HHS / United States
R01 AI117535 / AI / NIAID NIH HHS / United States
R01 AI137198 / AI / NIAID NIH HHS / United States
R01 AI146180 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021